Across 4753 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by 브리짓라이프사이언스, Executive. Director active across 2 companies, notably 엔지켐생명과학. Cumulatively, 18,471 reports have been logged. History available since 24 February 2026. The latest transaction was filed on 26 February 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Bridget Life Science is an Executive at Enzychem Lifescience. In this role, he is involved in managing operations and contributes to the overall strategy of the company. His expertise in the sector is an asset for the development of new products and innovation within the organization.